Report overview
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Inherited Genetic Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Inherited Genetic Disorders. This report contains market size and forecasts of Gene Therapy for Inherited Genetic Disorders in global, including the following market information:
Global Gene Therapy for Inherited Genetic Disorders Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy for Inherited Genetic Disorders market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.
We surveyed the Gene Therapy for Inherited Genetic Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy for Inherited Genetic Disorders Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, by Type, 2022 (%)
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Global Gene Therapy for Inherited Genetic Disorders Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Research Institute
Others
Global Gene Therapy for Inherited Genetic Disorders Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy for Inherited Genetic Disorders revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy for Inherited Genetic Disorders revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy for Inherited Genetic Disorders, market overview.
Chapter 2: Global Gene Therapy for Inherited Genetic Disorders market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy for Inherited Genetic Disorders company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy for Inherited Genetic Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
